Else Beth Trautner

Women in Life Science Denmark (WiLD) is a leading Nordic network for senior women across the Danish life science ecosystem, and part of a Nordic collaboration with WiLD Norway and VILDA Sweden. WiLD brings together executives, board members, experienced specialists, and top-level scientists from industry and academia. Our purpose is to strengthen value creation in Danish life science by unlocking the full potential of diverse talent at executive and senior specialist levels. We create a science-centric, inspiring forum that increases the visibility and influence of women in top leadership roles. Through role modelling, mentoring, knowledge sharing, and public engagement, WiLD members actively contribute to shaping a more inclusive, competitive, and future-ready life science sector. By making women leaders visible today, we inspire the next generation to realise their full potential and step into leadership tomorrow.

Danske Hoteller, der i dag består af 26 spændende individuelle kroer, hoteller og konferencecentre, tilbyder oplevelser af høj kvalitet, hvad enten der er tale om forretningsovernatninger, romantiske weekendophold, en oplevelsesrig miniferie for hele familien, golf på alle niveauer, firmafester, den runde fødselsdag eller et koncentreret kursusforløb. Vores varemærke er kvalitet til fornuftspriser, hvor alle kan være med. Alle vores lokale hotelværter er ambassadører for deres lokalområde og er altid klar til at modtage Dem som vores gæster.

Three established Finnish life science & diagnostics pioneers Abacus Diagnostica, Labrox and Kaivogen have merged into Uniogen. Uniogen is specialized in molecular and immunoassay diagnostics of infectious diseases, cancer diagnostics, and laboratory instrumentation. We are targeting the global market with new, innovative solutions under development for early cancer detection and for point-of-care testing of infectious diseases, among others.

BoardPartner er en erhvervsforening af erfarne og professionelle bestyrelsesmedlemmer, som har til formål at hjælpe ejerledere og danske virksomheder med ledersparring og etablering af professionel bestyrelse, samt at være en netværks- og videndelings-organisation for erfarne virksomhedsledere, der arbejder professionelt med bestyrelsesarbejde. #bestyrelse #bestyrelsedk #bestyrelsesposter #bestyrelsesprofiler #boardpartner

Women in Life Science Denmark (WiLD) is a leading Nordic network for senior women across the Danish life science ecosystem, and part of a Nordic collaboration with WiLD Norway and VILDA Sweden. WiLD brings together executives, board members, experienced specialists, and top-level scientists from industry and academia. Our purpose is to strengthen value creation in Danish life science by unlocking the full potential of diverse talent at executive and senior specialist levels. We create a science-centric, inspiring forum that increases the visibility and influence of women in top leadership roles. Through role modelling, mentoring, knowledge sharing, and public engagement, WiLD members actively contribute to shaping a more inclusive, competitive, and future-ready life science sector. By making women leaders visible today, we inspire the next generation to realise their full potential and step into leadership tomorrow.

Danske Hoteller, der i dag består af 26 spændende individuelle kroer, hoteller og konferencecentre, tilbyder oplevelser af høj kvalitet, hvad enten der er tale om forretningsovernatninger, romantiske weekendophold, en oplevelsesrig miniferie for hele familien, golf på alle niveauer, firmafester, den runde fødselsdag eller et koncentreret kursusforløb. Vores varemærke er kvalitet til fornuftspriser, hvor alle kan være med. Alle vores lokale hotelværter er ambassadører for deres lokalområde og er altid klar til at modtage Dem som vores gæster.

Three established Finnish life science & diagnostics pioneers Abacus Diagnostica, Labrox and Kaivogen have merged into Uniogen. Uniogen is specialized in molecular and immunoassay diagnostics of infectious diseases, cancer diagnostics, and laboratory instrumentation. We are targeting the global market with new, innovative solutions under development for early cancer detection and for point-of-care testing of infectious diseases, among others.

ProInvent A/S provides technology for manufacturing and delivers production equipment for the industrial businesses. ProInvent was established in 1994 and has since succeeded in being a competent partner for Danish and international businesses, among others: Velux, LeoPharma, Novo Nordisk, Novozymes, Xellia Pharmaceuticals, Cook Medical, Coloplast, ConvaTec, Pressalit and Haldor Topsøe. To these companies ProInvent has developed equipment and processes that has increased operation profits and improved the working environment for the operators. The ProInvent Group A/S is employing 32 people and consists of ProInvent A/S (technology development) and Videometer A/S (vision technology) which was founded in 1999. Projects with inspection equipment are normally structured with ProInvent A/S as the main contractor and Videometer as a subcontractor. ProInvent is experienced and competent in delivering assembly lines, inspection machines, handling equipment and industrial automation. We have succeeded in realising many significant development projects, both minor and large-scale projects. The majority of the employees are qualified engineers. Several of ProInvent's employees have at least 15 years of experience with technology development and integrated product development. The vision of ProInvent is to be a strong organization in growth with top professional engineers who understand how to unite creativity and business. ProInvent is able to provide the customers with optimum technical solutions on the basis of a healthy economy in the investments which ProInvent contributes to realise. The objective of ProInvent is to be a competent partner for development-intensive industrial enterprises and to assist them in development of production and inspection systems – and to help them to achieve a more efficient production, higher earnings'​ growth and an improved working environment.

Cbio A/S is a biopharmaceutical company developing next generation T-cell therapies against solid tumors. We are soon to enter our First-in-Human clinical study at Karolinska Hospital in Sweden with our proprietary T-cell product, novoleucel, where the T-cell are armed against oxidative stress. We are located in Copenhagen, Denmark in a 1,000 m2 state-of-the-art facility where we develop and produce cell-based therapy products for clinical use.